Chongqing Pharscin Pharmaceutical Co., Ltd.

Chongqing Pharscin Pharmaceutical Co., Ltd. - PE Ratioverified

002907.SZ

Price:

$14.9

Market Cap:

$6.22B

Chongqing Pharscin Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company actively involved in the research, development, manufacturing, and distribution of medicines. Its product portfolio encompasses a broad spectrum of pharmaceutical formulations, such as tablets, powders, granules, hard and soft capsules, alongside various injectables including powder, freeze-dried powder, and small volume injections. The company also specializes in active pharmaceutical ingredient (API) synthesis. This diverse range of products targets critical therapeutic areas, including the central nervous system (CNS), digestive health, otolaryngology, oncology, as well as cardiovascular and cerebrovascular co...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2017-10-20

Stock Exchange

SHZ

Ticker

002907.SZ

The PE Ratio as of October 2026 (TTM) for Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ) is 83.94

According to Chongqing Pharscin Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 83.94. This represents a change of -1397.48% compared to the average of -6.47 of the last 4 quarters.

Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ) Historical PE Ratio (quarterly & annually)

How has 002907.SZ PE Ratio performed in the past?

The mean historical PE Ratio of Chongqing Pharscin Pharmaceutical Co., Ltd. over the last ten years is 75.58. The current 83.94 PE Ratio has changed 11.01% with respect to the historical average. Over the past ten years (40 quarters), 002907.SZ's PE Ratio was at its highest in in the December 2021 quarter at 778.02. The PE Ratio was at its lowest in in the December 2025 quarter at -209.18.

Quarterly (TTM)
Annual

Average

75.58

Median

69.53

Minimum

24.15

Maximum

197.45

Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Chongqing Pharscin Pharmaceutical Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 176.79%

Maximum Annual PE Ratio = 197.45

Minimum Annual Increase = -63.42%

Minimum Annual PE Ratio = 24.15

Quarterly (TTM)
Annual
YearPE RatioChange
202592.5628.16%
202472.22-63.42%
2023197.45132.75%
202284.838.10%
202178.4875.44%
202044.7312.77%
201939.67-27.68%
201854.85-17.94%
201766.84176.79%
201624.15-22.22%

Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ) Average PE Ratio

How has 002907.SZ PE Ratio performed in the past?

The current PE Ratio of Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

120.74

5-year avg

105.11

10-year avg

75.58

Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ) PE Ratio vs. Peers

How is 002907.SZ’s PE Ratio compared to its peers?

Chongqing Pharscin Pharmaceutical Co., Ltd.’s PE Ratio is greater than ChengDu ShengNuo Biotec Co.,Ltd. (15.34), greater than Hunan Warrant Pharmaceutical Co.,Ltd (31.96), greater than Shanxi Zhendong Pharmaceutical Co.,Ltd (-13.02), greater than Jiangsu Jibeier Pharmaceutical Co., Ltd. (26.40), greater than Zhejiang Yatai Pharmaceutical Co., Ltd. (-400.00), greater than Beijing Science Sun Pharmaceutical Co., Ltd. (-23.49), greater than Shenzhen Neptunus Bioengineering Co., Ltd. (-4.97), greater than Guizhou Xinbang Pharmaceutical Co., Ltd. (49.83), greater than Shanghai Kaibao Pharmaceutical CO.,Ltd (21.45), less than Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (186.84),

Build a custom stock screener for Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chongqing Pharscin Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Chongqing Pharscin Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Chongqing Pharscin Pharmaceutical Co., Ltd.'s PE Ratio?

How is the PE Ratio calculated for Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ)?

What is the highest PE Ratio for Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ)?

What is the 3-year average PE Ratio for Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ)?

What is the 5-year average PE Ratio for Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ)?

How does the current PE Ratio for Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ) compare to its historical average?